Polish γδ T cell research group is localized in Lublin at the Department of Clinical Immunology, Medical University of Lublin, Poland. The group is headed by prof. Michał Zarobkiewicz. Working of the group is focused on γδ T cells in cancer and the optimisation of γδ T cells for cellular immunotherapy.
The group is financed by both internal Medical University programs and external ones. The following grants are currently carried out:
Interactions between γδ T lymphocytes and M-MDSC cells in the pathogenesis of chronic lymphocytic leukemia
2020-2025 2019/35/N/NZ6/02973 – Polish National Science Center
Modern drugs in the treatment of chronic lymphocytic leukemia – impact on γδ T lymphocytes
2023-2024 PBmn 161 – Medical University of Lublin
Impact of selected Btk inhibitors on γδ T cells and γδ T immunotherapy
2023-2025 DKMS Foundation
γδ T lymphocytes in type II diabetes mellitus and their therapeutic potential
2023-2024 MNiE SKN/SP/570637/2023 – Ministry of Higher Education and Science
Team leader
Researcher
Doctoral student
